AURO-LEVOCARB
AURO-LEVOCARB
Approved
DIN Number
02531607
Drug Class
Human
Market Date
Apr 14, 2023
Company
HC
auro pharma inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02531607
AIG Number0210315003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BA02 LEVODOPA AND DECARBOXYLASE INHIBITOR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:36.16
Health Canada Classification
ACTIVE INGREDIENTS (2)
CARBIDOPAActive
Strength: 25 MG
Monograph: CARBIDOPA
LEVODOPAActive
Strength: 100 MG
Monograph: LEVODOPA